OrbiMed Genesis GP LLC just provided an update on activist position in Theravance

OrbiMed Genesis GP LLC just filed a "Statement of acquisition of beneficial ownership", which is also known as a 13D. In the filing, it appears as though OrbiMed Genesis GP LLC claims to own 16,838,668 shares. This represents 43.5% of Theravance.

Please note that typos are common in SEC filings. Please verify the information reported above before acting on it.

To receive a free e-mail notification whenever Theravance makes a similar move, sign up!

Auto Refresh

Feedback